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A B S T R A C T
The aim of the study was to assess the prevalence of depression among Croatian patients infected with human immu-
nodeficiency virus (HIV) and to make a comparison with patients with other acute and chronic infectious diseases. We as-
sessed the depressive disorder using the Beck Depression Inventory questionnaire (BDI), without clinical confirmation.
The BDI scores were examined in 80 HIV-infected persons and compared to 80 persons with chronic viral hepatitis and
78 with acute infectious diarrhea. All examinees were treated as outpatients at the University Hospital for Infectious Dis-
eases in Zagreb in March and April of 2003. Prevalence of moderate and severe depression among HIV-infected was
16/80 (20%) with a 95% confidence interval 11% to 29%. Male patients with HIV or chronic viral hepatitis had a signifi-
cantly higher BDI scores than males with acute infectious diarrhea (p=0.017, Kruskall-Wallis, d.f. 2). Female patients
with HIV infection tended to have a lower BDI score than females with chronic viral hepatitis or acute infectious diar-
rhea (p=0.087, Kruskall-Wallis, d.f. 2). Prevalence of moderate and severe depression among Croatian HIV-positive pa-
tients is higher than the upper estimate for general population. Croatian males with chronic infectious disease have
higher rate of depression than those with acute infectious disease.
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Introduction
According to the latest report more than 40 million
people worldwide is infected with HIV1. In countries
where antiretroviral treatment is available it is expected
that HIV-infected patients will be able to live otherwise a
healthy live for many years. As with other serious ill-
nesses such as cancer, heart disease or stroke, HIV-dis-
ease can often be accompanied by depression, an illness
that can affect mind, mood, body and behavior2,3. Treat-
ment of depression helps people to manage both diseases,
thus enhancing survival and quality of life. Infected indi-
viduals face the prospect of social stigma, long-term
physical discomfort and illness, and eventual death. De-
pression is often not recognized and begins to affect
many people at a relatively young age. It is an increasing
burden of health care system4,5, hence examining the
rate of depression is of considerable interest.
There was no previous estimate of the prevalence of
depression among Croatian adult population with HIV
infection. The aim of this study was to estimate the prev-
alence of moderate and severe depression among Cro-
atian HIV-infected patients and to make a comparison to
patients with chronic and acute infectious diseases. As
an example of a chronic infectious disease we chose
chronic viral hepatitis (any type of hepatitis virus). Pre-
vious studies in USA, UK, Germany and France have
shown a relatively high prevalence of depression (range:
16% to 35%) in individuals with chronic viral hepa-
titis6–10. On the contrary, we could not find any reference
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on the association of acute infectious diarrhea (as an ex-
ample of acute infectious disease) with increased depres-
sion rate. We tested the hypothesis that there was no dif-
ference in BDI scores between the three groups defined
by their infectious disease.
Patients and Methods
All of the examinees were recruited from the Outpa-
tient Department of the University Hospital for Infec-
tious Diseases in Zagreb, where all Croatian HIV-in-
fected are treated. The individual had to have confirmed
HIV-infection with a Western-blot antibody test and had
to be at least 18 years old. Exclusion criteria were an ac-
tive opportunistic infection or actual major psychiatric
disorder. 83 consecutive patients were approached, of
whom 80 were included in the study. One patient was ex-
cluded due to opportunistic infection and two refused to
participate in the study so the final response rate was
80/83. The study was conducted between 1st March to
30th April of 2003.
We assessed depression using the Beck Depression In-
ventory (BDI) instrument. The BDI is a self-adminis-
tered 21 item self-reported scale measuring supposed
manifestations of depression. The BDI score between 9
and 18 implies mild to moderate depression, between 19
and 30 moderate to severe depression, and over 30 severe
depression11. Due to somatic nature of some symptoms of
depression (insomnia, loss of appetite, loss of weight,
fatigability) that could be caused by some other dis-
eases/conditions, it is usual to analyze total BDI score
and BDI score without somatic symptoms11. We did not
do clinical confirmation of depressive disorder.
We administrated the same questionnaire to patients
with chronic viral hepatitis (three of 83 eligible refused
to complete the questionnaire, response rate 80/83.), and
to the patients with acute infectious diarrhea as an ex-
ample of acute infectious disease (five out of 83 eligible
refused to participate, response rate 78/83). They were
recruited the same way as HIV-patients at the same hos-
pital and in the same period of time. The calculation of
the sample size was based on a 20% of prevalence of de-
pression with an 18% confidence interval width and 0.05
level of significance12. We got approval to conduct the
study from the Ethical board of the University Hospital
for Infectious Diseases in Zagreb.
Statistics
The outliers were checked for entering errors and
were not excluded from further analysis13. We used the
Shapiro-Wilk’s test for checking the assumption of nor-
mality and Levene’s test for checking the assumption of
homogeneity of variance. Due to the absence of normal-
ity and homoscedasticity, we used rank-sum tests for
testing differences between groups: Kruskall-Wallis test
for three groups and Mann-Whitney U test for two
groups14. We chose a=0.05 as a level of significance. For
comparing two-by-two groups the Bonferroni correction
was used to avoid error due to multiple comparisons15: all
p values were multiplied with the number of compared
group which was 3. The analysis was performed by Epi
Info, version 3.2, provided by the Centers for Disease
Control and Prevention, Georgia, USA (http://www.cdc.
gov/epiinfo/downloads.htm).
Results
The median age of 80 HIV-infected patients was 39
years (range 12.5). The median of BDI score was 8.5
(range 13.75). Sixty-five out of 80 (81%) examinees were
males and 64 out of 80 (80%) had taken highly-acti-
vated-antiretroviral-therapy (HAART). The median of
age among 80 examinees with chronic viral hepatitis
group was 38.5 years (range 20.5) and the median of BDI
score was 9 (range 18). Fifty-four out of 80 (68%) were
males. The median age of 78 patients with acute infec-
tious diarrhea was 36 years (range 24). The median of
BDI score was 6 (range 9) and 46 out of 78 (59%) were
males (Table 1).
Age and BDI scores were not normally distributed
(both p values less than 0.001, Shapiro-Wilk’s). There
was no statistically significant difference between groups
regarding age (p=0.264, Kruskall-Wallis, d.f. 2). Due to
the difference in gender distribution between groups
(p=0.009, Kruskall-Wallis, d.f. 2) we stratified out analy-
sis by gender (Figure 1).
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TABLE 1
MEDIANS OF BECK DEPRESSION INVENTORY SCORES (RANGE) IN PATIENTS WITH HIV INFECTION, CHRONIC HEPATITIS C AND
ACUTE INFECTIOUS DIARRHEA
HIV-patients CVH-patients AID-patients
males
(N=65)
females
(N=15)
males
(N=54)
females
(N=26)
males
(N=46)
females
(N=33)
Total BDI score 9 (14)* 6 (18)† 8 (17) 14 (19) 5 (13) 9 (7)
BDI score without somatic symptoms 6 (10)‡ 4 (11)§ 6 (10) 8 (16) 1 (4) 4 (4)
*p=0.017 and ‡p<0.001, comparison of scores in males, Kruskall Wallis test, d.f.=2.
† p=0.087 and § p=0.068, comparison of scores in females, Kruskall Wallis test, d.f.=2
BDI – Beck Depression Inventory, HIV – Human immunodeficiency virus, CVH – Chronic viral hepatitis,
AID – Acute infectious diarrhea
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Prevalence of moderate to severe depression (BDI
score >18) among HIV-infected patients was 16/80 (20%)
with 95% confidence interval (CI) 11% to 29%. Preva-
lence of severe depression (BDI>30) was 4/80 (5%) with
95% CI 0.3% to 9.7%.
We failed to reject the null hypothesis (there was no
difference in total BDI score between three groups) in the
female stratum (p=0.087, Kruskall-Wallis, d.f. 2). How-
ever, in the male stratum we found a statistically signifi-
cant difference among BDI scores (p=0.017, Kruskall-
Wallis, d.f. 2). We also compared 2 by 2 groups in the male
stratum and found a significantly higher BDI score in the
HIV-group compared to the acute infectious diarrhea
group (p=0.034, Mann-Whitney U with Bonferroni cor-
rection), and in the chronic viral hepatitis compared to the
acute infectious diarrhea group (p=0.036, Mann-Whitney
U with Bonferroni correction). There was no significant
difference between HIV and chronic viral hepatitis groups
(p=0.94, Mann-Whitney U).
When we compared the distributions of BDI scores
without somatic symptoms between the three groups
similar results were observed: statistical significance was
not achieved for females (p=0.068, Kruskall-Wallis, d.f.
2), while in the male stratum we found a statistically sig-
nificant difference (p <0.001, Kruskall-Wallis, d.f. 2).
When we compared 2 by 2 groups in the male stratum,
we found again a significantly higher BDI score without
somatic symptoms in the HIV-group compared to the
acute infectious diarrhea group (p<0.001, Mann-Whit-
ney U with Bonferroni correction), and in the chronic vi-
ral hepatitis group compared to the acute infectious diar-
rhea group (p=0.005, Mann-Whitney U with Bonferroni
correction). There was no significant difference between
HIV and chronic viral hepatitis groups (p=0.7, Mann-
Whitney U) (Table 1).
Discussion
We found that the prevalence of moderate to severe
depression in HIV-infected patients in Croatia is 20%
with a 95% CI 11% to 29% which is higher than the upper
estimate for the general population (10%)5. Unfortu-
nately, there are no population studies on depression
prevalence in Croatia, so we used the World Health Orga-
nization estimate which is general and with no stratifica-
tion according to different subtypes of depression. De-
pression seems to be one of the main causes of poor
adherence to anti-retroviral therapy16. It should be de-
tected and treated as soon as possible because of the po-
tential risk of attempted or successful suicide17,18. Both
depression and potential suicide attempts could become
an important problem for health care providers5,19.
Over the past 15 years, numerous studies estimated the
prevalence of depression, particularly major depressive dis-
orders, in HIV-positive individuals20,21. These rates differed
dramatically, from 0%22 to 48%23. Many studies concluded
that HIV infection is not associated with a higher rate of
depressive disorder22,24–29. On the other hand, other studies
and meta-analytic studies as well, provided strong evidence
that HIV infection is associated with greater risk for major
depressive disorder23,30,31. It is almost impossible to make a
precise comparison of those prevalence rates because there
is no unique and simple method of depression diagnosis.
The most accurate diagnostic of depression is a structured
clinical interview which is time consuming and difficult to
perform in a routine practice. We used the Beck Depression
Inventory in our study because it is a standardized ques-
tionnaire easy to interpret; it has been widely used for a
long period of time and; it is simple to perform and a useful
screening test.
Due to the gender distribution in our sample and
known differences in depression prevalence between ma-
les and females in some populations5, we stratified our
analysis by gender. However, there is lot of inconsistency
regarding gender and the prevalence of depression in dif-
ferent populations5,22–31.
Our study has several limitations. A larger case-con-
trol or cohort study is needed to quantify the crude risk
of developing depression in people with chronic infec-
tious diseases and investigate possible cause-effect. It
would be also interesting to make a more detailed inves-
tigation of the association of various characteristics of
the chronic infectious disease (for example: prognosis,
social stigma, adverse effect of therapy, etc.) to depres-
sive disorders. Hence, we might have neglected some pos-
sible confounders in our study such as other comor-
bidities. For the estimation of the prevalence rate we
used a convenient sample which could have also intro-
duced a selection bias. Another difficulty is to compare
studies on depression prevalence due to different depres-
sion diagnostics and lack of age standardization among
patients with chronic infectious diseases.
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Fig. 1. Boxplot of total Beck depression index (BDI) scores among
males (p=0.017, Kruskall-Wallis, d.f. 2) and females (p=0.087,
Kruskall-Wallis, d.f. 2). Medians, quartiles, minimum-maxi-
mum ranges and outliers are presented. Grouping variable: in-
fectious disease – Acute infectious diarrhea (AID), Chronic viral
hepatitis (CHV), Human immunodeficiency virus (HIV).
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Despite these limitations, our study is of good infor-
mative value and we have shown that depression is an
important co-morbidity in Croatian patients suffering
from chronic hepatitis and HIV disease. It should be rec-
ognized and treated appropriately.
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PREVALENCIJA UMJERENO TE[KE I TE[KE DEPRESIJE
U HRVATSKIH BOLESNIKA ZARA@ENIH HIV-OM
S A @ E T A K
Cilj istra`ivanja bio je utvrditi u~estalost depresije u hrvatskih bolesnika zara`enih virusom humane imunodefi-
cijencije (HIV) te usporediti s u~estalo{}u u bolesnika s drugom akutnom i drugom kroni~nom bole{}u. Prevalenciju
smo procijenili kori{tenjem Beck Depression Inventory upitnika (BDI), bez klini~ke potvrde dijagnoze. Zbroj BDI bo-
dova utvr|en je u 80 bolesnika zara`enih HIV-om te uspore|en s 80 osoba oboljelih od kroni~nog virusnog hepatitsa i 78
oboljelih od akutnog infektivnog proljeva. Svi ispitanici bili su ambulantni klijenti Klinike za infektivne bolesti »Dr.
Fran Mihaljevi}« iz Zagreba u o`ujku i travnju 2003. g. U~estalost umjereno te{ke i te{ke depresije u HIV-om zara`enih
osoba bila je 16/80 (20%) uz 95% interval pouzdanosti 11% do 29%. Mu{ki ispitanici zara`eni HIV-om ili kroni~nim
virusnim hepatitisom imali su statisti~ki zna~ajno vi{i zbroj BDI bodova od mu{karaca oboljelih od akutnog infektivnog
proljeva (p=0,017, Kruskall-Wallis, d.f. 2). @ene zara`ene HIV-om imale su ni`i zbroj BDI bodova od `ena zara`enih
kroni~nim virusnim hepatitisom ili akutnim infektivnom proljevom (p=0,087 Kruskall-Wallis, d.f. 2). U~estalost umje-
rene do te{ke depresije u hrvatskih bolesnika zara`enih HIV-om je ve}a nego gornja procjena za op}u populaciju. Mu-
{karci s kroni~nom zaraznom bole{}u imaju vi{u u~estalost depresije od onih s akutnom zaraznom bole{}u.
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